Neurodegenerative Diseases: pathogenic mechanisms
Group leaders
Manuel Guzmán Pastor
Ismael Galve Roperh
Tlf. 0034 91 394 46 68
Principal Investigator
- Javier Palazuelos Diego
Collaborating Staff
- Cristina Blázquez Ortiz
- Eva Resel Mariné
- Carlos Costas Insúa
- Tania Aguado Sánchez
- Samuel Simón Sánchez
- Alicia Álvaro Blázquez
- Tánia Gavaldá Vives
- Alba Hermoso López
- Sara Ezquerro Herce
Group leaders
Manuel Guzmán Pastor
Ismael Galve Roperh
Tlf. 0034 91 394 46 68
Principal Investigator
- Javier Palazuelos Diego
Collaborating Staff
- Cristina Blázquez Ortiz
- Eva Resel Mariné
- Carlos Costas Insúa
- Tania Aguado Sánchez
- Samuel Simón Sánchez
- Alicia Álvaro Blázquez
- Tánia Gavaldá Vives
- Alba Hermoso López
- Sara Ezquerro Herce
STRATEGIC OBJECTIVES
To study the molecular mechanisms by which cannabinoid receptors act in the brain, as well as the potential validity of these receptors as therapeutic targets in the fields of neurodegeneration, neurorepair, and neuro-oncology. To characterize new mechanisms of action and effects mediated by cannabinoid receptors and to suggest new pathophysiological implications arising from them.
RESEARCH LINES
- Neurogenesis and neurorepair via cannabinoid receptors.
- Neuroprotection via cannabinoid receptors.
Location
Complutense University of Madrid
Faculty of Biological Sciences
Department of Biochemistry and Molecular Biology
Keywords
Neurodegeneration, neurogenesis, neuro-repair, neuropharmacology, cannabinoid